The Valley Desk

NCT05200364 · Interventional trial

A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer

Overall registry status Terminated

Phase 1

Conditions Fallopian Tube Cancer, Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer, Primary Peritoneal Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov